CIK 0001701108
- Non-accelerated filer
- Smaller reporting company
Spero Therapeutics, Inc.
Sign in to watch- Ticker
- SPRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-242-1600
- Business address
- 675 MASSACHUSETTS AVENUE, 14TH FLOOR, CAMBRIDGE, MA, 02139
- Former names
- Spero Therapeutics, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $42,485
- in 1 filing
Net −$42,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-31 | Aquilo Capital Management, LLC 10% owner | Purchase | +48,645 | $18.93 | $921K | 4,358,030 |
| 2021-08-30 | Aquilo Capital Management, LLC 10% owner | Purchase | +44,042 | $17.87 | $787K | 4,309,385 |
| 2021-08-27 | Aquilo Capital Management, LLC 10% owner | Purchase | +13,957 | $16.88 | $236K | 4,265,343 |
| 2021-08-26 | Melnick David A. Chief Medical Officer | Grant or award | +24,067 | 24,067 | ||
| 2021-08-26 | Mahadevia Ankit CEO and President | Grant or award | +78,219 | 144,036 | ||
| 2021-08-26 | Larkin Cristina Chief Operating Officer | Grant or award | +24,067 | 25,567 | ||
| 2021-08-26 | JOSEPH TAMARA L Chief Legal Officer | Grant or award | +24,067 | 24,067 | ||
| 2021-08-26 | Keutzer Timothy Chief Development Officer | Grant or award | +24,067 | 26,567 | ||
| 2021-08-26 | Shukla Sath Chief Financial Officer | Grant or award | +24,067 | 24,067 | ||
| 2021-08-26 | Aquilo Capital Management, LLC 10% owner | Purchase | +22,982 | $16.55 | $380K | 4,251,386 |
| 2021-08-24 | Aquilo Capital Management, LLC 10% owner | Purchase | +40,170 | $16.28 | $654K | 4,228,404 |
| 2021-08-23 | Aquilo Capital Management, LLC 10% owner | Purchase | +137,835 | $16.33 | $2.3M | 4,188,234 |
| 2021-08-20 | Aquilo Capital Management, LLC 10% owner | Purchase | +221,190 | $14.86 | $3.3M | 4,050,399 |
| 2021-08-17 | Pottage John C Jr Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2021-08-17 | Smith Cynthia Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2021-08-17 | Deshpande Milind Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2021-08-17 | THOMAS FRANK E Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2021-08-17 | VINK PATRICK V.J.J. Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2021-08-17 | Jackson Scott Thomas Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2021-08-17 | FORMELA JEAN FRANCOIS Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 |
Page 9 of 17 · 340 trades